These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6040625)

  • 1. Modern management of the menopause; this deficiency disease, caused by lack of ovarian hormone, should be treated throughout life by estrogen replacement therapy.
    Castallo MA
    Pa Med; 1967 May; 70(5):80-1. PubMed ID: 6040625
    [No Abstract]   [Full Text] [Related]  

  • 2. [Menopause and hormone replacement therapy].
    Tóth KS
    Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian failure following cancer treatment: current management and quality of life.
    Absolom K; Eiser C; Turner L; Ledger W; Ross R; Davies H; Coleman R; Hancock B; Snowden J; Greenfield D;
    Hum Reprod; 2008 Nov; 23(11):2506-12. PubMed ID: 18664468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current trends in hormone replacement therapy.
    Khashoggi TY
    Saudi Med J; 2002 May; 23(5):495-502. PubMed ID: 12070567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal management of migraine at menopause.
    Nappi RE; Sances G; Detaddei S; Ornati A; Chiovato L; Polatti F
    Menopause Int; 2009 Jun; 15(2):82-6. PubMed ID: 19465675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and the menopause: a global overview.
    Barrett-Connor E
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():6-14. PubMed ID: 8499961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the hematochemical parameters and bone mineral density of women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and surgical menopause treated with estrogen replacement. Part II].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):215-22. PubMed ID: 17576400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormone replacement therapy of menopause and mortality].
    Scarabin PY
    Rev Epidemiol Sante Publique; 1997 Oct; 45(5):440-1. PubMed ID: 9446149
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacokinetics and efficacy of different estrogens are not equivalent.
    Ansbacher R
    Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and syndrome X.
    Collins P
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():68-71; discussion 71-2. PubMed ID: 8624346
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.
    Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J
    Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New trial to test hormone therapy in younger women.
    Harv Womens Health Watch; 2005 Nov; 13(3):6. PubMed ID: 16408352
    [No Abstract]   [Full Text] [Related]  

  • 17. Hormonal management of migraine associated with menses and the menopause: a clinical review.
    Loder E; Rizzoli P; Golub J
    Headache; 2007 Feb; 47(2):329-40. PubMed ID: 17300386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of efficacy of estrogen and phytotherapy in oral cavity alterations of women in menopause.
    Giuca MR; Carli E; Pasini M; Bonfigli D; Cappè MR
    Minerva Ginecol; 2009 Feb; 61(1):13-22. PubMed ID: 19204657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects.
    Helgason S
    Acta Obstet Gynecol Scand Suppl; 1982; 107():1-29. PubMed ID: 6282033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.
    Dubey RK; Imthurn B; Barton M; Jackson EK
    Cardiovasc Res; 2005 May; 66(2):295-306. PubMed ID: 15820198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.